Herbert Baraf, MD, FACP, FACR
Clinical Associate Professor of MedicineUNIVERSITY OF MARYLAND
Member of the Healthcare Council
Herbert Baraf, MD, FACP, FACR, is the Managing Partner of Arthritis and Rheumatism Associates and the Medical Director of Center for Rheumatology and Bone Research in Maryland. He is also the Clinical Professor of Medicine at George Washington University Medical Center and Clinical Associate Professor of Medicine at University of Maryland. Dr. Baraf is a member of Scleroderma Foundation of Greater Washington, Rheumatism Society of the District of Columbia, where he served as President, and the Board of Directors of the Metropolitan Washington Chapter of Arthritis Foundation. (This is me - Update Profile)
| 1998 - present | Clinical Associate Professor of Medicine UNIVERSITY OF MARYLAND |
|---|---|
| 1983 - present | Medical Director Center For Rheumatology & Bone Research |
| 1979 - present | Clinical Professor of Medicine George Washington University Medical Center - CC |
| 1978 - present | Managing Partner Arthritis & Rheumatism Associates, PC (inc) |
GLG Study Groups with Herbert Baraf, MD, FACP, FACR(?)
| Study Group Name | Members |
|---|---|
| Enbrel Prescribers for RA (US) | 24 |
| Physicians Who Treat Gout (US) | 126 |
| Bosentan Prescribers for PAH (US) | 72 |
| Rheumatologists | 869 |
GLG NewsSM Analyses by Herbert Baraf, MD, FACP, FACR(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Herbert Baraf, MD, FACP, FACR has not published any public GLG News analyses.
View all GLG News in Healthcare
View all GLG News in Healthcare
GLG InstituteSM Seminars with Herbert Baraf, MD, FACP, FACR(?)
Herbert Baraf, MD, FACP, FACR has not participated in any GLGi Seminars.
View all GLG InstituteSM Seminars in Healthcare
View all GLG InstituteSM Seminars in Healthcare
Request a project with Herbert Baraf, MD, FACP, FACR
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.
GLG's 750+ Clients Include:
40 of the leading 50
global mutual funds
global mutual funds
15 of the leading 20
global banks
global banks
8 of the leading 10
private equity firms
private equity firms
90%+ client subscription renewal rate

